[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Phase One, Open Label, Homologous Reinfection with Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) or Dengue-3-Virus-Live Virus Human Challenge (DENV-3-LVHC) Virus Strains

What is the purpose of the study? (in Layman's terms, please describe the study)

To investigate the response of subjects to a re-inoculation with the same strain of dengue virus, or to investigate the response of subjects who have never been inoculated with or had dengue virus

Upstate Institutional Review Board (IRB) Number:

2079925

Study/Protocol ID:

2023-01-UMU

Study Phase:

1

Patient Age Group:

Adults

Principal Investigator:

Stephen J Thomas

Who is eligible?

Adults age 18-55

What is involved if I participate?

  • How long is the study?
    6-9 monts
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Blood draws, inoculation with dengue virus, maintaining an e-diary

Where will the study take place?

Global Health Research Unit
4900 Broad Rd, POB-North Suite 4U
Syracuse NY 13215

Other Information:

May not be immunosuppressed, must be able to commit to frequent in-person and phone visits.

Who can I contact for more information?

Name: Kianna Ripich
Phone: 315-464-6488
Email: [email protected]

Return to Previous Page || Search Again

Top